Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1375393 | Bioorganic & Medicinal Chemistry Letters | 2010 | 4 Pages |
We report herein a novel series of difluoropiperidine acetic acids as modulators of γ-secretase. Synthesis of 2-aryl-3,3-difluoropiperidine analogs was facilitated by a unique and selective β-difluorination with Selectfluor®. Compounds 1f and 2c were selected for in vivo assessment and demonstrated selective lowering of Aβ42 in a genetically engineered mouse model of APP processing. Moreover, in a 7-day safety study, rats treated orally with compound 1f (250 mg/kg per day, AUC0–24 = 2100 μM h) did not exhibit Notch-related effects.
Graphical abstractThe discovery and optimization of a novel class of difluoropiperidine acetic acid γ-secretase modulators is described. These compounds selectivity inhibit the formation of the more pathogenic Aβ42 without impacting Aβ40 production and, importantly, undesired Notch cleavage.Figure optionsDownload full-size imageDownload as PowerPoint slide